← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 1, 2022Last known activity
Oct 1, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 4 trials)
Phase 3 (2 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Recent trials (8)
- NCT07260006Lead sponsorN/AOct 1, 2024
- NCT07260006Sponsor investigatorN/AOct 1, 2024
- NCT06963788OfficialPhase 3Feb 6, 2024
- NCT06963788Lead sponsorPhase 3Feb 6, 2024
- NCT07265102OfficialN/ASep 5, 2023
- NCT07265102Lead sponsorN/ASep 5, 2023
- NCT06558461Lead sponsorPhase 2/Phase 3Jun 1, 2022
- NCT06558461OfficialPhase 2/Phase 3Jun 1, 2022
Details
- Last known activity
- Oct 1, 2024